Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations

Buchwald, Peter·2010·IUBMB Life
DOI 10.1002/iub.383

Cited by (140)

Items 101–140 of 140

  1. Protein-protein interaction and interference of carcinogenesis by supramolecular modifications
    Oluwatosin A. Saibu, Opeyemi Sodiq Hammed, Oladapo O. Oladipo, Tope Tunji Odunitan, Temitope M. Ajayi, Aderonke J. Adejuyigbe, Boluwatife T. Apanisile, Oluwatoba Emmanuel Oyeneyin, Adenrele T. Oluwafemi, Tolulope Ayoola et al. · 2023 · Bioorganic & Medicinal Chemistry
  2. Restoration of p53 Functions By Suppression of mortalin–p53 Sequestration: an Emerging Target in Cancer Therapy
    H.S. Akshatha, Meduri Bhagyalalitha, Gurubasavaraj V. Pujar, Raghu Chandrashekar Hariharapura, Arun Kumar Sethu, Manisha Singh, Durgesh Paresh Bidye · 2023 · Future Medicinal Chemistry
  3. Interface Peptide Mimetics-Rationale and Application as Therapeutic Agents
    Mythily Srinivasan · 2016 · Medicinal Chemistry
  4. Targeting Cas Family Proteins as a Novel Treatment for Breast Cancer
    Joerg Kumbrink, Kathrin Halfter · 2011 · InTech eBooks
  5. - Library Design, Chemical Space, and Drug Likeness
    Hugo O. Villar · 2015 · CRC Press eBooks
  6. Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
    Yvonne Xinyi Lim, Yvonne Xinyi Lim, Sock Hong Seah, Yoon Pin Lim · 2021 · Cells
  7. Discovery of a Small-Molecule Inhibitor Targeting the Biofilm Regulator BrpT in Vibrio vulnificus
    Wonwoo Choi, Hojun Lee, Qiyao Wang, Ye‐Ji Bang, Sang Ho Choi · 2024 · Journal of Microbiology and Biotechnology
  8. Small-molecule Modulators of Protein–Protein Interactions: Focus on 14-3-3 PPIs
    Leire Iralde-Lorente, Maurizio Botta, Christian Ottmann · 2020 · Royal Society of Chemistry eBooks
  9. The Drug Discovery and Development Process
    Nicholas S. Bodor, Péter Buchwald · 2012 · Wiley eBooks
  10. Insights into the mechanism of hyaluronic acid and its derivatives reducing starch digestibility: Gelatinization, multiscale structures, and enzyme activity
    Kangyu Wang, Xiaojie Qin, Yue Liu, Liwei Qi, Yujie Guo, Chunhui Zhang · 2025 · LWT
  11. Hydrogel-Bead Particles Enable Activity-Based Identification of Nucleic Acid Aptamer Enzyme Inhibitors
    Amanda A. Nguyen, Brian M. Paegel · 2025 · Analytical Chemistry
  12. Molecular Imaging of Protein–Protein Interactions and Protein Folding
    Tarik F. Massoud, Ramasamy Paulmurugan · 2021 · Elsevier eBooks
  13. Library Design, Chemical Space, and Drug Likeness
    Hugo O. Villar · 2015 · CRC Press eBooks
  14. Drug Design Methods to Regulate Protein–Protein Interactions
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
  15. Current Drug Targets and the Druggable Genome
    Margaret A. Johns, Andreas Russ, Haian Fu · 2012 · Cambridge University Press eBooks
  16. ML-Driven Approach to Discovery of Peptide-Based BACE1 Inhibitors
    Nicholas Chen · 2025 · International journal of high school research
  17. Exploring the phytochemical composition and the anticancer potential of Haliclona fascigera and Stylissa carteri Red Sea sponges in colon cancer treatment: A promising approach
    Samah Sulaiman Abuzahrah, Nouf Juaid, Tahani Bakhsh, Serag Eldin I. Elbehairi, Mohammed Abbas Baghdadi, Reham Hassan Mekky · 2025 · Current Research in Biotechnology
  18. Research Progress on the Structural Biology of Paramyxovirus Polymerase and Its Inhibitors
    Jinyuan Wu, Sining Tao, An-Chao Ge, Zhongxia Zhou, Dongwei Kang, Xinyong Liu · 2026 · Journal of Medicinal Chemistry
  19. Overcoming phenotypic switching: targeting protein-protein interactions in cancer
    Christos Ap. LADIAS, Pavlos Papakotoulas, Maria Papaioannou, Nikolaos A. Papanikolaou · 2023 · Exploration of Targeted Anti-tumor Therapy
  20. Overview of Protein-Protein Interactions and Small-Molecule Inhibitors Under Clinical Development
    Guoqiang Dong, Chunquan Sheng · 2018 · Springer eBooks
  21. Overview of Drug Discovery Targeting PPI Systems
    Hao Ma, Jian Zhang · 2025 · Wiley eBooks
  22. Development of an in vitro assay system for protein phosphatase inhibitor-1 antagonists
    Hannieh Sotoud · 2012
  23. The Structural Basis of Gβ5-RGS7 Interaction with the Muscarinic M3 Receptor and Implications for its Role in Functional Pathway Selectivity
    Darla Karpinsky‐Semper · 2014
  24. Design of peptide and small molecule inhibitors of cyclin dependent kinase 9/cyclin T1 protein-protein interaction using computational methods
    Jelena Randjelović · 2013
  25. Discovery of Novel Tubulin Polymerization Inhibitors and Survivin Inhibitors as Potential Anticancer Agents
    Min Xiao · 2015
  26. machine interaction modulators via a dedicated support vector protein - : a tool for filtering orthosteric protein HUNTER 2P2I
    Jean Michel Brunel, Sébastien Combes, Xavier Morelli, Philippe Roche, Véronique Hamon, Isabelle Théret, Laura Xuereb · 2013
  27. Targeting the menin-MLL-LEDGF Interaction with Small Molecule Inhibitors.
    Jonathan Pollock · 2016 · Deep Blue (University of Michigan)
  28. Recent Trend in Physical Sciences
    2021 · Lincoln Research and Publications Limited, Australia in Collaboration with Lincoln University College, Malaysia eBooks
  29. A Global Method for Simulating Intracellular Signaling Reduces Computational Time In Multiscale Agent-Based Models With Translational Systems Biology Applications
    Daniel R. Bergman, Randy F. Sweis, Alexander T. Pearson, Fereshteh Nazari, Trachette Levon Jackson · 2021 · SSRN Electronic Journal
  30. Platelet ITIM-Containing Receptors
    Eva M. Soriano Jerez, Craig E. Hughes · 2025 · Springer eBooks
  31. Inhibiting ubiquitin ligases: a case study on the discovery, mechanism, and optimization of Cbl-b inhibitors
    Alex J. Chinn, Taylor R. Quinn, Jeffrey A. Boerth, Keishi Kohara, Gayathri Bommakanti · 2026 · Elsevier eBooks
  32. Synthesis and biological evaluation of potential CGRP antagonists : application to chronic pain
    Nishanth Kandepedu · 2015
  33. Evolution of protein motifs in their structural context : from mining motif resources available to the prediction of phenotype-specific motifs
    Paul de Boissier · 2022
  34. BindingDB Entry 50002244: Complexity of Blocking Bivalent Protein-Protein Interactions: Development of a Highly Potent Inhibitor of the Menin-Mixed-Lineage Leukemia Interaction.
    BindingDB · 2020 · UC San Diego
  35. BindingDB Entry 50044412: Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction.
    BindingDB · 2015 · UC San Diego
  36. BindingDB Entry 50006562: Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.
    BindingDB · 2024 · UC San Diego
  37. BindingDB Entry 50042999: Progress and developments in tau aggregation inhibitors for Alzheimer disease.
    BindingDB · 2014 · UC San Diego
  38. BindingDB Entry 50000798: Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.
    BindingDB · 2020 · UC San Diego
  39. BindingDB Entry 50047242: Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL).
    BindingDB · 2017 · UC San Diego
  40. BindingDB Entry 50006029: High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction.
    BindingDB · 2020 · UC San Diego